Br J Nutr 2000,84(6):829–838.PubMed check details 30. Okano G, Sato Y, Murata Y: Effect of elevated blood FFA levels on endurance

performance after a single fat meal ingestion. Med Sci Sports Exerc 1998,30(5):763–768.PubMedCrossRef 31. Jensen MD: Fate of fatty acids at rest and during exercise: regulatory mechanisms. Acta Physiol Scand 2003,178(4):385–390.PubMedCrossRef 32. Wolfe RR, Klein S, Carraro F, Weber JM: Role of triglyceride–fatty acid cycle in controlling fat metabolism in humans during and after exercise. Am J Physiol 1990,258(2 Pt 1):E382-E389.PubMed Selleck KPT330 competing interests The authors declare that they have no competing interests. Authors’ contributions All authors contributed to the study design, the muscle and blood collection procedure, biochemical analyses, statistical analysis, and preparation of the manuscript. All authors have read and approved the final manuscript.”
“Erratum to: OsteoporosisDOI

10.1007/s00198-008-0712-1 Tables 7, 8, 9, 10 and Figs. 2, 3, 4 of this article, inadvertently printed in black and white, were intended to be printed in colour. In addition there was an error in the scale Fedratinib ic50 of the y-axis of Fig. 4. The relevant tables and figures are reproduced below. Fig. 2 Relation between the 10-year probability of a major osteoporotic fracture and the 10-year probability

of a hip fracture in women aged 50 years from the UK. Each point represents a particular combination of BMD and clinical risk factors Fig. 3 Correlation between C-X-C chemokine receptor type 7 (CXCR-7) the probability of fracture and cost effectiveness at the age of 50 years in women (BMI set to 26 kg/m2). The upper panel shows the 10-year probability of hip fracture and the lower panel the probability of a major osteoporotic fracture. Each point represents a particular combination of BMD and clinical risk factors Fig. 4 Management chart for osteoporosis. The brown area in the left hand panel shows the limits of fracture probabilities for the assessment of BMD. The right hand panel gives the intervention threshold Table 7 Management decisions (N, no action; B, BMD testing at the femoral neck; T, treatment without BMD) in women according to risk factors and age (BMI=23.9) Table 8 Management decisions (N, no action; B, BMD testing at the femoral neck; T, treatment without BMD) in women according to risk factors and age (BMI=23.